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Web-based Physiotherapy for people affected by Multiple Sclerosis (WEBPaMS); a single 24 
blind, randomised controlled feasibility study 25 
 26 
Abstract 27 
Objective: To examine the feasibility of a trial to evaluate web-based physiotherapy compared 28 
to a standard home exercise programme in people with Multiple Sclerosis (MS).  29 
Design: Multi-centre, randomised controlled, feasibility study 30 
Setting; Three Multiple Sclerosis out-patient centres 31 
Participants: Ninety people with Multiple Sclerosis (Expanded Disability Disease Scale 4-6.5), 32 
Interventions: Participants were randomised, to a 6 month individualised, home exercise 33 
programme delivered via web-based physiotherapy (n=45) (intervention) or a sheet of 34 
exercises (n=45) (active comparator).  35 
Main outcome measures: Outcome measures (0, 3, 6 and 9 months) included adherence, 36 
2min walk test, 25ft walk, Berg Balance Scale, physical activity and healthcare resource use. 37 
Interviews were undertaken with 24 participants and 3 physiotherapists.  38 
Results: Almost 25% of people approached agreed to take part. No intervention-related 39 
adverse events were recorded. Adherence was 40-63% and 53-71% in the web-based 40 
physiotherapy and comparator groups. There was no difference in the 2min walk test 41 
between groups at baseline (Intervention-80.4(33.91)m, Comparator-70.6(31.20)m) and no 42 
change over time (at 6 months Intervention-81.6(32.75)m, Comparator 74.8(36.16)m). There 43 
were no significant changes over time in other outcome measures except the EQ-5D at 6 44 
months which improved in the active comparator group. For a difference of 8(17.4)m in the 45 
2min walk test between groups 76 participants/group would be required (80% power, p>0.05) 46 
for a future randomised controlled trial.  47 
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Conclusion: no changes were found in the majority of outcome measures over time. This 48 
study was acceptable and feasible by participants and physiotherapists. An adequately 49 
powered study needs 160 participants.  50 
Key words: Physiotherapy, Exercise, Multiple Sclerosis, Internet 51 
 52 
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Introduction 54 
People with Multiple Sclerosis benefit from rehabilitation (1), but access is limited in part 55 
because of resource limitations (2). Web-based interventions may overcome this since they 56 
can provide tailored programmes and improve access to specialist therapists or services 57 
particularly for those with work/family commitments, rural location or limited mobility (3–5); 58 
but further evidence is needed concerning its effectiveness and costs. Previous research on 59 
web-based interventions has examined the effectiveness of general physiotherapy 60 
programmes (3,6,7) or specific Multiple Sclerosis impairments such as balance (1,8), strength 61 
(9) or reduced physical activity (10,11).  62 
 63 
We previously undertook a 12 week randomised controlled pilot study to investigate web-64 
based physiotherapy for people with Multiple Sclerosis (Expanded Disability Status Score 65 
(EDSS) 5-6.5) (6). The results showed trends towards improvement in walking speed, 66 
symptoms and the physical impact of Multiple Sclerosis (6). Like previous studies, our initial 67 
study was limited by small sample size (3,7,8), and short intervention period (7,8). Therefore, 68 
the aim of this feasibility randomised controlled trial was to examine a six-month web-based 69 
physiotherapy exercise programme compared to a standard home exercise programme 70 
(active comparator) in people moderately affected by Multiple Sclerosis. The primary 71 
research objective was to estimate the sample size required for a future randomised 72 
controlled trial.  Secondary objectives included; a) to inform the recruitment strategy for a 73 
future trial; b) estimate attrition rates; c) estimate adherence to the intervention; d) identify 74 
baseline factors most strongly associated with outcomes, as potential stratification factors in 75 
the definitive trial; e) determine the acceptability and feasibility of web-based physiotherapy; 76 
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f) help establish the eligibility criteria for a definitive trial; g) undertake an exploratory cost-77 
effectiveness analysis of web-based physiotherapy compared to the active comparator. 78 
 79 
Methods and Materials 80 
The study was prospectively registered on ClinicalTrials.gov (Identifier: NCT02508961), ethical 81 
approval was obtained from the West of Scotland Research Ethics Service (Ref:15/WS/0030; 82 
March 2015- January 2016) and University of Glasgow acted as study sponsor. This 83 
randomised, controlled, multi-centre feasibility study aimed to recruit 90 people with 84 
Multiple Sclerosis from three centres (30 from each centre); NHS Ayrshire and Arran, NHS 85 
Lothian and Plymouth Hospitals NHS Trust, over a seven month period (June 2015-December 86 
2015). The sample size was based on previous pilot data (6) and the assumption that each 87 
centre could recruit one participant per week.  88 
 89 
Potential participants were identified through neurology, Multiple Sclerosis specialist 90 
nurse/physiotherapy clinics and from the Multiple Sclerosis regional register/iMED database 91 
in Plymouth; and were issued a letter of invitation. To be included participants were required 92 
to have a confirmed diagnosis of Multiple Sclerosis (12), an EDSS of 4.0-6.5 (13) and access to 93 
a personal computer/tablet with an email address and internet connection. Participants were 94 
excluded if they were currently taking part in regular exercise (≥ two times/week) and/or 95 
regular physiotherapy programme, had poor cognitive function (Mini Mental State 96 
Examination Score <24) (14), any significant change in medication or a relapse within the last 97 
three months,  other significant co-morbidities for which exercise would be contra-indicated 98 
or were currently participating in another clinical trial.  99 
 100 
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At the initial appointment potential participants were screened for eligibility, written 101 
informed consent was obtained and baseline assessments were performed. One week later 102 
participants’ were given an appointment with an experienced neurological physiotherapist 103 
where they received a standardised physiotherapy assessment. Goals were agreed, from 104 
which an individualised exercise programme was devised. Participants were then randomised 105 
to the intervention or active comparator group using a remote, telephone automated 106 
randomisation system within the Glasgow Clinical Trials Unit. Randomisation was stratified by 107 
study centre and EDSS (4.0-5.0 and 5.5-6.5). Participants were provided with their exercise 108 
programme either via web-based physiotherapy or as a printed sheet of exercises. All 109 
participants were asked to complete their exercise programme twice weekly and received a 110 
weekly telephone call/email for the first two weeks to discuss any issues.  111 
 112 
Outcome measures were performed at baseline, 3 months, 6 months (post intervention) and 113 
9 months (follow-up) by a blinded research assistant at each site. Primary outcome measures 114 
were adherence and the Two Minute Walk Test (15,16). Adherence was measured from the 115 
electronic (web-based physiotherapy) or returned paper diaries (active comparator). 116 
Participants were advised to undertake their physiotherapy programme twice per week for 117 
six months (2 x 26 weeks = 52 diary entries). Secondary outcome measures included the 118 
Timed 25 Foot Walk (17), Timed Up and Go test (18), Berg Balance Scale (19), Multiple 119 
Sclerosis Impact Scale v2 (20), MS-Related Symptom Checklist (21), Hospital Anxiety and 120 
Depression Scale (22), EQ-5D, (23) and steps taken/day measured objectively worn 121 
continuously for one week using the activPAL tri-axial accelerometer  (Pal Technologies Ltd, 122 
Glasgow, UK) (24,25). The device was attached to the participant’s mid-thigh using a 123 
waterproof Tegaderm dressing and participants kept a diary to record their sleep time. 124 
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Healthcare resource use, physiotherapist time, GP visits, nurse visits, other Multiple Sclerosis 125 
or outpatient review, Accident and Emergency attendance and hospital stay, were recorded 126 
by self-report questionnaire. 127 
 128 
To determine the acceptability and feasibility of the study semi-structured telephone 129 
interviews were undertaken with physiotherapists and participants. The interviewer was a 130 
member of the research team unknown to participants. A purposive sample of 24 131 
participants, eight from each study site (both groups), consented to take part.  The purposive 132 
sample was selected using a sampling matrix to include age (<50 years, >50 years), disability 133 
(EDSS 4.0-5.0, 5.5-6.5) and gender. Participants were asked their reasons for taking part in 134 
the study, their views of the assessments and intervention, any issues faced, perceived 135 
benefit and recommendations for a future trial. 136 
 137 
Web-based Physiotherapy 138 
Participants randomised to the web-based physiotherapy intervention received an 139 
individualised exercise programme delivered via www.webbasedphysio.com. Programmes 140 
could consist of cardiovascular, strengthening and balance exercises, as well as warm up, cool 141 
down and stretching exercises, at different levels of difficulty and a prescribed number of 142 
sets/repetitions individualised to meet the participants’ needs. The website contained 143 
exercises (videos, text and audio description) and disease-specific advice and education 144 
(described in Paul et al. (6)).  During the intervention period the physiotherapist reviewed 145 
electronic exercise diaries every two weeks and remotely altered programmes in response to 146 
a participant’s comments. Alterations could include changing exercises, difficulty level or 147 
number of repetitions/sets. Participants were informed of any changes by email.  148 
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 149 
Active comparator  150 
Participants randomised to the active comparator intervention received a printed sheet of 151 
exercises (www.physiotherapyexercises.com). Programmes consisted of similar exercises as 152 
above. Participants completed a paper-based exercise diary that was posted to the research 153 
team every three months.  154 
 155 
The three physiotherapists also consented to take part in a telephone interview. They were 156 
asked regarding their experiences of delivering the interventions, issues in operationalising 157 
the protocol and recommendations for a future trial. 158 
 159 
Data analysis 160 
All analyses were performed on an intention to treat basis using SAS for windows v9.3. 161 
Categorical variables are summarised as number and percentage (n(%)). Continuous variables 162 
were summarised by mean and standard deviation (SD) or median and interquartile range 163 
(IQR) as appropriate.  Adherence data were considered as those who recorded no exercise 164 
sessions per four week period, non-adherence (<75% of completed sessions) and adherence 165 
(≥75% of completed sessions) and was compared between intervention groups using Chi-166 
squared tests.  Between group differences were assessed using analysis of covariance 167 
(ANCOVA) adjusted for baseline value and stratification variables (centre and EDSS) and 168 
Cohen’s (d) effect sizes were calculated (26).    169 
 170 
Cost-effectiveness was explored using healthcare resource use and valued using UK cost 171 
sources (27–29). EQ-5D data were used to derive health utility values and estimate quality-172 
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adjusted life-years (QALYs) gained (30). Mean costs and QALYs associated with each 173 
treatment group were estimated using generalised linear models.  Telephone interviews were 174 
audio-recorded, transcribed verbatim and analysed using thematic analysis. One researcher 175 
first coded all scripts, then two researchers independently identified emerging themes and 176 
sub-themes. Following this, discussion was held between the researchers to agree and finalise 177 
themes and sub-themes.  178 
 179 
Results 180 
Ninety people with Multiple Sclerosis were recruited (Figure 1), however to achieve our target 181 
sample size the data collection period was extended from seven to twelve months (June 2015-182 
May 2016) (Figure 2). The sample consisted of 21 males and 69 females; mean age 56.1 (SD 183 
9.6) years (Table 1). Eight people (18%) from the intervention group and five (11%) from the 184 
active comparator group withdrew from the study (Figure 1) (31). One participant received 185 
the web-based physiotherapy intervention rather than the active comparator, although with 186 
intention to treat analysis they were considered as having received the comparator 187 
intervention.  188 
 189 
Figure 1 Near Here 190 
Figure 2 Near Here 191 
Table 1 Near Here 192 
 193 
Between 40%-63% of participants adhered to the web-based physiotherapy intervention 194 
(≥75% completed diaries) and between 53%-71% to the active comparator during each four 195 
week period (Table 2). In both groups adherence reduced over time but over 40% of 196 
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participants were still adhering to their programme at 6 months. The proportion of people 197 
who had no diary entries was 16-24% in the intervention group and 22-27% in the comparator 198 
group. No significant differences were found between both groups. 199 
 200 
Table 2 Near Here 201 
 202 
Compared to baseline, there were no changes in the majority of outcome measures, in either 203 
group, at three, six and nine months, with the exception of the EQ-5D at six months in the 204 
active comparator group (Table 3).  205 
 206 
Table 3 Near Here  207 
 208 
Sixty adverse events were recorded; intervention group (n=27), active comparator group 209 
(n=33) and 42 of these were falls.  Two participants had skin reactions due to the Tegaderm. 210 
None of the adverse events were deemed to be related to the intervention.  211 
 212 
Telephone interviews were completed by 8 men and 16 women (mean age 56.2 (SD 9.6) years, 213 
11 received web-based physiotherapy and 13 the comparator intervention (EDSS 4.0 n=4, 214 
EDSS 4.5 n=3, EDSS 5.0 n=1, EDSS 6.0 n=11, EDSS 6.5 n=5)). Analysis of the interview 215 
transcripts yielded three themes and 13 subthemes (Table 4). Participants had a variety of 216 
reasons for taking part in the study, most wanted to get back to exercise to improve their 217 
physical condition but for some a realistic goal was to maintain their physical ability.  Taking 218 
part in the study was stated as a way of getting more therapy, providing a sense of purpose 219 
and to help others with Multiple Sclerosis.   220 
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 221 
Table 4 Near Here 222 
 223 
In general, participants were very positive about the study, some people had a preference in 224 
terms of group allocation, often determined by previous experience, but no-one felt very 225 
strongly. A number of people suggested an additional appointment with the physiotherapist 226 
to review progress would have been beneficial. Participants from both groups appreciated 227 
the individualised nature of their programme. There was notable variation in the number of 228 
exercises participants reported and very few instances of exercise programmes being 229 
changed or progressed. Most people reported some benefit from exercising and gave 230 
examples of both Multiple Sclerosis (e.g. fatigue) and non- Multiple Sclerosis related factors 231 
(e.g. holidays or surgery) which affected their adherence.  Participants in the comparator 232 
group reported that completing the exercise diary was motivating. Finally some suggestions 233 
were proposed to improve the web-based physiotherapy website including being able to 234 
retrospectively complete exercise diaries.  235 
 236 
Analysis of the transcripts from the physiotherapists’ interviews resulted in three themes and 237 
nine sub-themes (Table 5). There were some challenges with recruitment mentioned as other 238 
studies were recruiting at the same time. All three therapists commented that some 239 
participants had a significant distance to travel for assessments which may have affected the 240 
outcomes due to fatigue. The physiotherapists reported that it only took a few minutes to 241 
review diaries through web-based physiotherapy and suggested being able to retrospectively 242 
add diary entries would have been useful. The therapists reported initial goals were not 243 
reviewed, and stated that another appointment would have been useful. Participants rarely 244 
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left comments in their diaries which meant that the physiotherapists were unable to 245 
change/progress their programme. When changes were made it tended to be a change in the 246 
dose of the exercise rather than add/change the exercise. 247 
 248 
Table 5 Near Here 249 
 250 
The results of the within-trial analysis found that the web-based intervention was associated 251 
with lower costs (£954), compared to standard treatment (£1,076).  This was associated with 252 
a small QALYs gain in the intervention group (0.557), compared with the comparator group 253 
(0.517). We undertook a bootstrap analysis to explore uncertainty associated with our results.  254 
The results estimated a mean cost difference between treatment groups of -£122 (95% CI: -255 
583.856, 339,206) and a mean difference in QALYs of 0.03 (95% CI: -0.012, 0.072).  Although 256 
the web-based intervention had the potential to dominate the standard treatment, as it 257 
provides additional QALYs for a lower cost, there is substantial uncertainty associated with 258 
these estimates.   259 
 260 
Discussion 261 
Adherence to the intervention was good, 40-63% in the web-based physiotherapy group and 262 
53-71% in the comparator group, with the lowest adherence during the last month of the 263 
study. Direct comparison with previous studies is challenging due to different methods of 264 
defining adherence, although all demonstrated that adherence to web-based physiotherapy 265 
reduces over time (9,10,32). Tallner et al. (9) reported that 73% of participants completed 266 
80% or more of their programme during months 1-3 which reduced to 36% during months 4-267 
6, Motl et al. (10) reported 96% of participants logged on to the website in weeks 1-2 which 268 
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reduced to 52% at week 8, and Conroy et al. (3) reported only half of participants adhered to 269 
their programme and almost one quarter completed no exercise diaries. 270 
 271 
Adherence to home-based exercise is affected by factors such as low motivation, pain and 272 
past experience of exercise (33). Participants in the active comparator group reported that 273 
completing and returning the exercise diaries improved their adherence. Return of exercise 274 
diaries is not part of usual care and may have inflated adherence in this group. Although our 275 
adherence was better than previous studies it is clear that other strategies to improve 276 
adherence e.g. more contact with a health care professional and more frequent updates are 277 
required (32). Specific strategies are needed to engage those with no diaries entries. 278 
 279 
In terms of recruitment, 24% of those invited to participate took part in the study.  There were 280 
no issues raised around the eligibility criteria. The recruitment rate of around two per month 281 
was less than the anticipated four per month per centre. Recruitment was generally on target 282 
for the first six months, however this recruitment rate was not maintained partly due to this 283 
study ‘competing’ for participants with other studies.  The most common pathway to 284 
recruitment was via the nurses or consultants. Thus, the recruitment strategy of a future trial 285 
would consider that around 1 in 4 of those invited will be recruited, would be predicated on 286 
an anticipated recruitment rate of two participants per month and would favour recruiting 287 
participants directly from clinics/health care staff.  288 
 289 
Although there were no significant changes in outcome measures, participants in both groups 290 
maintained their clinical outcomes over the intervention period and, during interview, a 291 
number of participants reported improvements in e.g. walking, balance and strength. 292 
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Multiple Sclerosis is a progressive neurological condition and some participants reported their 293 
goal was to maintain their functional status rather than improve.  Similarly, Conroy et al. (3) 294 
recruited people with Multiple Sclerosis with levels of disability similar to the current study 295 
and reported no significant improvement in outcomes following a six month web-based 296 
physiotherapy intervention. Web-based exercise may have the potential to maintain the 297 
clinical status of people with Multiple Sclerosis with higher levels of disability, however 298 
further investigation with the inclusion of a control group with no exercise intervention, to 299 
assess the natural history of participants, is required.  300 
 301 
The dose of exercise prescribed may explain the lack of improvement in outcome measures. 302 
Similar to Conroy et al. (3), our study took place within the context of available resources, 303 
with exercise programmes reflecting physiotherapy practice (including aerobic, 304 
strengthening, cardiovascular and functional exercises).  Only one similar, small, uncontrolled, 305 
short-term (12 week) web-based physiotherapy study found some improvements in people 306 
with Multiple Sclerosis (7). In contrast, previous web-based studies in Multiple Sclerosis that 307 
have focussed on a single impairment e.g. strengthening (9), physical activity (10) or balance 308 
(8) have reported positive results. It is possible that with a combined programme, the dose of 309 
exercise for any one component is insufficient for physiological changes to take place thus 310 
web-based interventions need to focus on specific impairments in order to achieve 311 
meaningful change.   312 
 313 
Few participants left comments in their exercise diaries therefore therapists had no clinical 314 
rationale to change programmes, which resulted in a lack of exercise progression.  The 315 
physiotherapists were reluctant to add exercises without seeing the participant to ensure 316 
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they were doing new exercises correctly and any progress tended to be an increase in 317 
repetitions of the same exercises, this was also raised by Conroy et al. (3). Delivering 318 
physiotherapy programmes remotely is a different service delivery model, which appears to 319 
challenge professional practice and values.   320 
 321 
From the data of this study and clinical experience it is estimated that the difference in Two 322 
Minute Walk Test between intervention and comparator groups would be 8m, assuming a 323 
standard deviation of 17.4m. Therefore, for 80% power at the 0.05 significance level 76 324 
participants per group would be required for a future definitive randomised controlled trial. 325 
However, attrition across the study period was 18% in the intervention group and 11% in the 326 
active comparator group which is notably less than previous web-based interventions of 327 
similar duration; 39% attrition Tallner et al. (9) and 35% attrition Conroy et al. (3). Thus, 328 
allowing for a conservative dropout rate of 20%, 95 participants per group would be required. 329 
 330 
The estimated differences in costs and QALYs between groups were small and further 331 
research to reduce the uncertainty associated with these estimates would be beneficial.  The 332 
association between changes in functional status and changes in Health-related Quality of Life 333 
remains unclear in the literature, particularly given the questionable sensitivity of the EQ-5D 334 
in people with Multiple Sclerosis (34). While some studies have found some improvement in 335 
Health-related Quality of Life in people with Multiple Sclerosis (8,35,36), others found no 336 
change (6,7,11). Further research is required to determine the impact of web-based 337 
physiotherapy on Health-related Quality of Life in people with Multiple Sclerosis and the 338 
suitability of EQ-5D. 339 
 340 
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This study has a number of limitations. Paper exercise diaries were used in the active 341 
comparator group to measure adherence however this is not part of usual care and may have 342 
increased adherence levels. The study did not include a non-exercising control group 343 
therefore comparisons to the natural history of Multiple Sclerosis cannot be made. Exercise 344 
programmes were individually tailored to participants to reflect clinical practice, however this 345 
meant that dose of exercise varied greatly and there were few examples of progression of 346 
programmes. This lack of progression was due to the paucity of diary comments and therefore 347 
a reluctance on the part of the therapists to progress exercises without face-to-face contact. 348 
As such the exercise dose may have been insufficient to induce physiological changes and 349 
hence outcome measures.  350 
 351 
This study has established the recruitment strategy for a definitive RCT of web-based 352 
physiotherapy for people moderately affected by Multiple Sclerosis. There are however a few 353 
uncertainties which require to be addressed before progressing to a full RCT. These include 354 
strategies to reduce the variation in prescribed exercise dose e.g. manualising the 355 
intervention, determining the number and format of contacts with healthcare staff to 356 
optimise adherence and outcomes, and providing staff education/training in the remote 357 
delivery of services. 358 
 359 
Acknowledgements 360 
We would like to that the Multiple Sclerosis Society for funding this study (Ref 11), the 361 
physiotherapists and assessors (Kim Algie, Nicholas Campbell, Rachel Dennett, Hayley 362 
Jasper, Caroline Macguire, Sara McCorkell) and all our participants. 363 
 364 
17 
 
Conflicts of Interest 365 
The authors declare that there are no conflicts of interest. 366 
 367 
Clinical Messages 368 
 The web-based physiotherapy based intervention was piloted and found to be feasible 369 
and acceptable to both participants and physiotherapists, with no intervention-370 
related adverse events 371 
 The Two Minute Walk Test and other secondary outcome measures were suitable 372 
however further consideration of the sensitivity of EQ-5D in Multiple Sclerosis is 373 
required 374 
 Based on the Two Minute Walk Test, for 80% power, at the 0.05 significance level, 76 375 
participants per group would be required for a future definitive randomised controlled 376 
trial 377 
 378 
 379 
 380 
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Table 1. Demographic characteristics of participants.  484 
 Intervention group 
(n=45) 
Active control 
(n=45) 
All  
(n=90) 
Age (years) 55.6 (10.2) 56.5 (9.1) 56.1 (9.6) 
Gender 13 M, 32 F 8 M, 37 F 21 M, 69 F 
BMI (kg/m2) 25.8 (5.1) 26.4 (5.6) 26.1 (5.3) 
Type of MS 
Benign 
PPMS 
SPMS 
RRMS 
Unknown 
 
0 (0%) 
11 (24%) 
14 (31%) 
15 (33%) 
5 (11%) 
 
1 (2%) 
5 (11%) 
17 (38%) 
15 (33%) 
7 (16%) 
 
1 (1%) 
16 (18%) 
31 (34%) 
30 (33%) 
12 (13%) 
TSD(years) 
Median [IQR] 
 
10[6-18] 
 
15 [10-23] 
 
12 [6-20] 
EDSS  (median [IQR]) 6.0 [6-6] 6.0 [6-6] 6.0 [6-6] 
Data values are mean (SD) for continuous variables and n (%) for categorical variables unless 485 
otherwise stated. 486 
Abbreviations- n-number; BMI: Body Mass Index; MS: Multiple Sclerosis; PPMS: Primary 487 
Progressive MS; SPMS: Secondary Progressive MS; RRMS: Relapsing Remitting MS; TSD: 488 
Time Since Diagnosis; EDSS: Expanded Disability Disease Steps; IRQ: Interquartile Range 489 
  490 
24 
 
Table 2. Adherence rates to the exercise programme in both intervention and active 491 
comparator groups. 492 
 493 
   Adherence  Intervention 
(n=45)  
 
 Active 
Comparator 
(n=45) 
 
Week 1-4 0 times 7 (16)  10 (22)  
  <75% 11 (24)  3 (7)  
  ≥75% 27 (60)  32 (71)  
          
Week 5-8 0 times 8 (18)  12 (27)  
  <75% 9 (20)  5 (11)  
  ≥75% 28 (62)  28 (62)  
          
Week 9-12 0 times 10 (22)  11 (24)  
  <75% 14 (31)  7 (16)  
  ≥75% 21 (47)  37 (60)  
          
Week 13-16 Withdrawn   5 (11)  3 (7)   
0 times 11 (24)  9 (20)  
  <75% 6 (13)  7 (16)  
  ≥75% 23(51)  26 (58)  
          
Week 17-20 Withdrawn 5 (11)  3 (7)   
0 times 11 (24)  8 (18)  
  <75% 9 (18)  6 (13)  
  ≥75% 20 (47)  28 (62)  
          
Week 21-24 Withdrawn  5 (11)  3 (7)   
0 times 10 (22)  12 (27)  
  <75% 12 (27)  6 (13)  
  ≥75% 18 (40)  24 (53)  
Data values are presented as n(%). P-values from Chi-squared, withdrawn category not included. 0 494 
times refers to those who recorded no exercise sessions per four week period, non-adherence (<75% 495 
of completed sessions) and adherence (≥75% of completed sessions) 496 
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Table 3. Mean values and change in outcomes at three, six months and nine months from baseline. 498 
 Intervention (n=45) Active control (n=45) Difference between groups 
 
 
Outcomes N Mean (SD) Mean change (SD) N Mean (SD) Mean change (SD)  Mean difference (95% CI)* Effect size (d) 
2 minute walk test (m)  
Baseline 45 80.4 (33.91)  45 70.6 (31.20)    
3 months 39 87.0 (32.88)  5.18 (17.81) 40 77.3 (33.82) 4.85 (17.33)  2.23 (-5.54, 10.01) 0.07 
6 months 37 81.8 (33.22)  0.77 (15.12) 39 74.8 (36.16) 3.32 (19.48) -1.14 (-9.49, 7.21) -0.04 
9 months 35 81.6 (32.75) -2.61 (16.19) 36 77.6 (33.64) 5.05 (20.43) -5.83 (-14.61, 2.95) -0.19 
MS Symptom Checklist  
Baseline 45 34.5 (13.47)  45 37.5 (13.45)    
3 months 39 31.0 (13.05) -2.95 (8.10) 40 34.8 (13.22) -1.55 7.56) -1.87 (-5.35, 1.62) -0.14 
6 months 38 33.3 (14.90) -1.45 (9.11) 39 36.1 (13.33) -0.25 (8.87) -1.47 (-5.59, 2.64) -0.11 
9 months 36 31.8 (11.99) -1.45(9.09) 36 34.4 (11.49) -0.45 (6.53) -1.41 (-4.88, 2.07) -0.12 
MSIS 29 v2 (physical) 
Baseline  45 51.3 (10.83)  45 51.3 (10.46)    
3 months 39 49.9 (11.32) -2.00 (7.22) 40  49.6 (10.95) -1.59 (5.51) -0.36 (-3.20, 2.48) -0.03 
6 months 38 52.6 (11.54) 0.55 (9.94) 39  50.6 (12.44) -0.17 (8.34) 1.05 (-3.09, 5.18) 0.10 
9 months 36 49.9 (11.28) -2.06 (8.18) 36 49.2 (11.46) -1.01 (8.16) -0.77 (-4.56, 3.01) -0.07 
MSIS 29 v2 (psychological) 
Baseline  45 19.2 (4.51)  45 19.7 (6.03)    
3 months 39 19.0 (4.96) -0.21 (3.03) 40  19.4 (5.68) -0.30 (3.14) 0.06 (-1.28, 1.41)  0.01 
6 months 38 20.2 (5.58) 0.76 (3.15) 39 20.0 (5.68) 0.44 (4.08) 0.47 (-1.12, 2.08) 0.09 
9 months 36 18.8 (5.16) -0.35 (3.92) 36 18.2 (5.13) -0.57 (4.02) 0.38 (-1.37, 2.14) 0.08 
BBS  
Baseline 43 42.3 (10.92)  44 40.3 (10.30)    
3 months 39 43.7 (11.2) 1.36 (4.21) 40 42.8 (9.22) 3.06 (5.76) -1.26 (-3.45, 0.93) -0.12 
6 months 37 43.2 (11.20) 0.81 (6.31) 39  42.3 (8.30) 1.86 (6.74) -0.52 (-3.40, 2.36) -0.05 
9 months 36 43.1 (11.93) 0.41 (6.86) 36 43.8 (8.98) 3.75 (6.69) -2.87 (-5.98, 0.24) -0.28 
T25ftW (ft/sec) 
Baseline 43 2.97 (1.26)  42 2.86 1.37)    
3 months 32 3.14 (1.20) 0.08 (0.51) 33 3.04 (1.32) 0.05 (0.73) 0.03 (-0.24, 0.30) 0.03 
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6 months  28 3.01 (1.27) -0.06 (0.62) 28  3.06 (1.71) 0.12 (1.43) -0.04 (-0.60, 0.53) -0.03 
9 months 27 3.02 (0.93) -0.03 (0.53) 32 2.99 (1.33) 0.13 (0.80) -0.05 (-0.38, 0.29) -0.04 
EQ-5D  
Baseline 45 0.73 (0.16)  45 0.70 (0.16)    
3 months 39 0.73 (0.13) 0.02 (0.12) 40 0.71 (0.16) 0.00 (0.17) 0.02 (-0.03, 0.08) 0.16 
6 months 38 0.74 (0.14) 0.03 (0.13) 39  0.65 (0.25) -0.06 (0.21) 0.10 (0.02, 0.17)** 0.61 
9 months 36 0.71 (0.16) -0.01 (0.10) 36  0.73 (0.18) 0.01 (0.14) -0.02 (-0.07, 0.04) -0.11 
EQ-5D VAS  
Baseline 45 64.8 (17.47)  45 63.1 (18.56)    
3 months 39 66.8 (18.79) 4.41 (15.40) 40  63.4 (19.87) -0.35 (17.12) 5.36 (-1.61, 12.34) 0.29 
6 months 38 66.2 (19.38) 0.68 (16.95) 39 60.28 (21.09) -4.56 (17.97) 5.27 (-2.28, 12.81) 0.29 
9 months 36 67.4 (17.93) 0.97 (16.97) 36 65.3 (19.19) -1.13 (16.27) 2.13 (-4.76, 9.02) 0.12 
TUG (s) 
Baseline 44 16.1 (8.98)  45 18.9 (11.47)    
3 months 35 14.3 (7.62) -0.90 (2.44) 40  19.0 (17.15) 0.07 (8.19) -0.06 (-2.77, 2.65) -0.01 
6 months 33 14.7 (6.55) -0.33 (3.39) 37 18.0 (10.66) -0.15 (4.20) -0.64 (-2.51, 1.23) -0.07 
9 months 34 14.6 (6.57) -1.43 (5.11) 36  16.6 (10.67) -1.20 (6.03) -1.00 (-3.32, 1.33) -0.10 
HADS - A 
Baseline 45 6.6 (3.35)  44 6.5 (3.87)    
3 months 39 6.2 (3.13) -0.33 (2.92) 39 6.4 (4.46) -0.05 (2.68) -0.33 (-1.51, 0.85) -0.09 
6 months 38 6.2 (3.60) -0.34 (3.18) 39 6.4 (4.72) -0.05 (3.15) -0.22 (-1.56, 1.13) -0.06 
9 months 36 5.8 (3.45) -0.62 (3.63) 36 5.5 (3.94) -0.45 (3.06) -0.06 (-1.49, 1.37) -0.02 
HADS - D 
Baseline 45 7.0 (3.57)  44 6.7 (4.01)    
3 months 39 6.9 (2.93) -0.01 (2.47) 39 6.3 (3.56) -0.64 (2.76) 0.68(-0.33, 1.67) 0.18 
6 months 38 6.6 (3.48) -0.32 (2.74) 39  6.9 (3.98) 0.23 (3.32) -0.41 (-1.70, 0.89)  -0.11 
9 months 36 6.5 (2.85) -0.03 (3.30) 36 6.0 (3.75) -0.29 (2.98) 0.38 (-0.86, 1.61) 0.11 
Steps/day 
Baseline 44 4451 (2511)  43 4584 (2788)    
3 months 29 3989 (2286) -296 (1560) 32 4303 (2633) 319 (1600) -551.2 (-1300.1, 197.8) -0.23 
6 months 33 4017 (2493) -454 (911) 35 4271 (2272) -54 (1830) -318.6 (-979.4, 342.1) -0.13 
9 months 29 3960 (2323) -570 (1177) 33 4410 (2910) -166 (1777) -381.7 (-1137.5, 374.2) -0.15 
27 
 
*Adjusted for baseline value and stratification variables (centre and EDSS). Abbreviations- CI: Confidence Interval, n-number; MS- Multiple Sclerosis; MSIS v2-499 
Multiple Sclerosis Impact Scale version 2; BBS- Berg Balance Scale; T25ftW- Timed 25ft Walk; VAS- Visual Analogue Scale; TUG- Timed Up and Go; HADS – Hospital 500 
Anxiety and Depression Scale; A- Anxiety subscale, D – Depression subscale. ** statistically significant (p ≤ 0.05). 501 
 502 
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Table 4. Findings of interviews with participants. 504 
Themes Subthemes Indicative quotes 
Reason for taking part Getting back to exercise  
 
“I used to go to the gym and, um, then I was unwell and I stopped going….so I thought this 
would be a good chance, sort of, ease in to sort of exercising again!” (P314) 
 To ‘give something 
back’/help others  
“I thought I owed something back, you know. I have had a lot of care and support and I thought 
I’d better give something back” (P123) 
“Why not? It might not help me but might help other people in the future” (P128) 
A sense of purpose 
 
“Often when you have MS you feel as if you’re being totally ignored…. It’s good that somebody is 
trying to do something positive for you” (P309) 
To get individualised 
physiotherapy 
“..recognised that it was a way to get access to physiotherapy…delay in trying to get seen by the 
community physiotherapist” (P210) 
“I’m not a sort of a group person either…but taking part too much with people with MS, it 
sounds sad but it just reinforces the misery sometimes” (P120) 
To improve/maintain 
physical fitness and/or 
function  
 
“Tightening up the core muscles” (P227) 
“Just to try and get some strength back into my muscles” (P129) 
“I am getting older anyway, I just want to keep the joints really as supple as I can (P316) 
…and maybe feel a bit fitter” (P121) 
“I was hoping to increase or no slow down or stop the declining mobile function” (P210) 
Study logistics Assessment/Outcome 
measures 
“They don’t always tell the full truth of how you are, to be honest” (P121) 
“[walking assessments] were difficult because I get good days and bad days” (P309) 
“[questionnaires]…would have been more appropriate for people who, dare I say it, are slightly 
more disabled than myself… are you depressed? Yeah just because of the football results” (P123) 
 Outcome of 
randomisation 
 
“I didn’t mind – either or” (P128) 
“I wanted the web of course. I am sure everyone wants the web! Because I am very ofay with 
using the laptop” (P114)  
“I’ve been given exercises by physios before, paper based and they’re not so motivating” (P316) 
“I was quite glad to get that one [control] I get ‘splitty’ head so I can’t sit on a computer” (A121) 
Need for an additional 
appointment  
with the physiotherapist 
“At least a second session with the physio after to try and cement it in a little better” (P324) 
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Exercise programme Exercise prescription and 
progression 
 
“She took into consideration all my weak points which I wanted to improve. So I’ve got weakness 
in my hips so we have exercises to try to counteract that” (P309) 
“Takes on average an hour a day” (P117)  
“Only had 4 exercises to do” (P218) 
“I don’t think it was hard enough…. I ‘m just doing the same exercises” (P218) 
 Adherence “Did it a couple of times then became ill. And then I broke my foot” (P218) 
“Had a long period when I did nothing… went on holiday to Australia… I was in patchy WiFi” 
(P330) 
“When there are other things on in the day I get tired and tend not to do exercise that day” 
(P314) 
“Didn’t do very much when it was the very hot weather, it was too much” (A129) 
Changes due to the 
exercise programme 
“I think my legs are a bit stronger. I can do the getting up and sitting down with control” (P328) 
“Found myself walking better” (P227)  
“Very confidence boosting” (P322) 
“I am finding them [exercises] harder now. I don’t know if that’s just a progression of the 
disease” (P121) 
“Difficult to tell …I think to sort of make much difference I would have to have more intensive 
exercise” (P314) 
Comparator Group 
 
 
 
 
 
“It [sheet of exercise] was good. I thought that, you know the explanation and that was very 
clear” (P314) 
“Yeah there was a picture and an explanation of what each exercise was and [physiotherapist] 
went through it at the beginning you know if I wasn’t doing it 100% right she could explain how 
to do it” (P210) 
“I think the fact that someone is looking at the sheet [exercise diary] helps you complete them…it 
gives you more of an impetus to do more exercise when you’re filling in a form” (P218) 
 Web-based Physio Group 
 
“It’s good, its good. … it’s very easy and you could follow it and comment on what you were 
doing… it’s made me feel more open to using things [computers] now than I would have done 
before” (P322) 
“If you see a video of somebody doing what you’re actually supposed to be doing then it’s like oh 
year I think I’ve got that” (P213) 
“I’d have liked to have been able to say ‘yesterday I did this’ but I couldn’t go back on the date 
and put anything in…” (P113) 
  505 
30 
 
Table 5. Findings of interviews with physiotherapists. 506 
Theme Subtheme Indicative quotes 
Study 
logistics/Feasibility 
Training of staff 
 
“I think it really helps with rapport building… the trial is feeling like a team” (T3) 
“Handouts we got from the training were great to refer back to… meant a bit more when I 
was actually involved and doing it” (T2) 
“Emails went out to the three of us that were the treating therapists … those kind of 
questions that needed teasing out, we did that all via email” (T3) 
“Having a mock patient would be good – to have someone as a practice” (T1) 
Participant recruitment 
 
“Most of them [participants] came through either the nurses or the consultants….I don’t think 
there were that many people who didn’t want to be involved” (T1) 
“We have the SMART drug trial here at the same time with the same EDSS, and people 
obviously couldn’t be part of both” (T3) 
“We had a couple who had very patchy or no internet access… one was in a rural area” (T2) 
NHS issues 
 
 
 
 
 
“Our manager has left again... We never quite knew who was dealing with what or how it 
had been left” (T1) 
“I ended up having to do a lot of work from home. A lot of it was down to [NHS area] security 
policies and things like that – IT stuff. I couldn’t access Dropbox and emails” (T1) 
“So we’d have sometimes use the corridor for the walk tests, but then you’d stop in between 
[people] coming and all kinds of practicality” (T3) 
“Me and [the assessor] had issues sometimes because we were sharing the office clinical 
space…”  (T2)  
Attendance and Adherence 
 
 
 
“A few of them [participants] had quite long journeys for us… they are always tired by the 
time they get here” (T1) “One person had a two hour drive to come for their assessment” (T3) 
“Constant juggling of appointments ... that was a challenge. That worked because she 
[assessor] was flexible” (T3) 
“People were on holiday … or the laptop was being used by their son … A few people became 
unwell which you would expect, non–related things like sickness bugs” (T2) 
Web-based 
physiotherapy 
Setting up a new patient 
 
“I think that was very easy to use actually. Very straightforward to set up a patient and 
modify it” (T2) 
“Trying to find an exercise that you knew in your head … trying to find if it was on the list. 
That took a bit of time” (T1) 
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Time to set up and review 
participants 
 
 
“So control group... maybe easily an hour [appointment with physiotherapist]. The 
intervention group probably… three quarters of an hour” (T2) 
“If there were lots of changes then [reviewing the programme] maybe 10 or 15 minutes but 
maybe only … 4-5 minutes if everything was OK” (T1) 
Suggested changes/additions to 
WBP 
“The main thing would be if you could communicate through the website” (T1) 
“Because you cant log it [exercise] retrospectively… I think sometimes the adherence data 
weren’t probably reflective of actually how much they’d done” (T2) 
“I had a few patients who were fairly disabled and could have really benefitted from perhaps 
some stretches but more in lying, like prolonged stretches … and then at the top end some 
dual tasking” (T3) 
Progressing the 
programme and 
reviewing goals 
Progressing the programme “If people made comments then I could change things. But if people made no comments then 
I couldn’t change things. I had to assume they were okay” (T3) 
“I felt like I’d abandoned them a bit” (T2) “I felt I should be doing more with them” (T1) 
“Sometimes the comments that were made weren’t guiding me in any way as to how they 
were getting on with it [programme]” (T2) 
“I think the temptation was to take out something that you thought it might be, but it was 
more difficult I think to add stuff in without ever seeing that person do the exercise….. So I 
think the natural reaction was to not add something, just to go up on the reps on the other 
things they still had in” (T3) 
Reviewing goals 
 
“If I say you at, I don’t know, six weeks in when you’d started to see some of those 
physiological changes... would things have improved enough that I could then yes push things 
up a bit? You don’t ever have that conversation” (T3) 
“We did set goals but we never reviewed them.. we should really review them” (T1) 
 507 
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Figure 1. Consort Diagram for pilot and feasibility trials for the WEBPAMS study. 511 
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Figure 2. Anticipated and actual recruitment across the study period. 513 
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